Healthcare -
Biotechnology - NASDAQ - US
$ 690.89
-1.12 %
$ 74.3 B
Market Cap
18.01
P/E
REGN - TOTAL LIABILITIES & EQUITY
Total Liabilities & Equity REGN - Regeneron Pharmaceuticals, Inc.
37.8 B
LAST VALUE
13.69%
2 YEAR CAGR
20.59%
5 YEAR CAGR
25.58%
10 YEAR CAGR